The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently defined as the worst pandemic disease. SARS-CoV-2 infects human cells via the binding of its S protein to the receptor angiotensin-converting enzyme (ACE2). The use of ACEIs/ARBs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jishou, Wang, Menglong, Ding, Wen, Wan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377983/
https://www.ncbi.nlm.nih.gov/pubmed/32712300
http://dx.doi.org/10.1016/j.lfs.2020.118142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377983/
https://www.ncbi.nlm.nih.gov/pubmed/32712300
http://dx.doi.org/10.1016/j.lfs.2020.118142

Ejemplares similares